Tiger BioSciences Showcases Innovation at IPAWS Conference
Tiger BioSciences made a significant impression as the headline sponsor of the International Post-Acute Wound Care Society Summit (IPAWS) Conference. This important event was an opportunity for the company to exhibit its extensive clinical data and innovation in wound care, placing them at the forefront of the industry.
Commitment to Advancing Wound Care
At the conference, Tiger BioSciences emphasized its dedication to enhancing wound care through scientific research, innovative products, and collaboration with leaders in the field. Garrett Grinsfelder, the President of Tiger Wound Care, expressed that their participation reflects their commitment to advancing patient outcomes through data-driven insights. The presentation centered on real-world evidence showcasing the significant clinical impact of their products.
Peer-Reviewed Clinical Studies
In the past year, Tiger BioSciences has contributed to five peer-reviewed retrospective studies that explore various aspects of wound care. These studies focus on chronic, surgical, and traumatic wounds, emphasizing the practical applications and outcomes of Tiger's advanced cellular, acellular, and matrix-like products, collectively referred to as CAMPs. This growing body of research underscores the effectiveness of their innovations in real healthcare settings.
Clinical Trials and Research Advancements
The company is also actively engaged in two key randomized controlled trials (RCTs). These trials are evaluating the efficacy of ACApatch and caregraFT in conjunction with Standard of Care treatments for patients suffering from several types of complex wounds, including venous leg ulcers, diabetic foot ulcers, and pressure ulcers. These initiatives are part of their broader goal to enhance patient care and recovery outcomes.
About Tiger BioSciences
Tiger BioSciences stands out as a vertically integrated cell and tissue technology company. Their operations extend through all phases of recovery, processing, and distribution, leading developments in revolutionary cellular, acellular, and matrix-like products. Their multifaceted approach positions them as a trusted partner to clinicians and a pioneer in tissue recovery and technology innovation.
Focus on Patient Care
At the essence of Tiger BioSciences’ mission is a commitment to improving the lives of patients and supporting healthcare providers and donor families. By leveraging innovative technologies and a compassionate approach, Tiger has positioned itself as a key player in transforming wound care and promoting healing. The continuous pursuit of advancement ensures their presence remains critical in the evolving landscape of medical treatment.
Frequently Asked Questions
What is the IPAWS Conference?
The IPAWS Conference is an event focused on advancements in post-acute wound care, where leading experts come together to share knowledge and research findings.
What innovations did Tiger BioSciences present?
Tiger BioSciences presented peer-reviewed clinical data demonstrating the efficacy of their cellular and acellular wound care products.
Why is clinical data important in wound care?
Clinical data is essential as it provides evidence of the effectiveness of wound care treatments, helping healthcare providers make informed decisions.
What types of wounds are being studied in the trials?
The ongoing trials are focusing on venous leg ulcers, diabetic foot ulcers, and pressure ulcers, seeking to improve treatment protocols for these conditions.
How does Tiger BioSciences support patient care?
The company supports patient care by innovating and providing products that enhance recovery outcomes, guided by scientific research and clinical evidence.
